Monday, February 29, 2016

Q BioMed Inc. (OTCQB: QBIO) CEO Provides Corporate Overview in an Interview With Scrip Intelligence: Developments in Vascular Therapeutics

›
Q BioMed Inc. (OTCQB: QBIO) CEO Provides Corporate Overview in an Interview With Scrip Intelligence: Developments in Vascular Therapeutics ...
Thursday, February 25, 2016

Aethlon Medical’s (Nasdaq: AEMD) Exosome Sciences Announces the Publication of Preliminary Findings of a Blood Test to Detect Chronic Traumatic Encephalopathy (CTE) During Life

›
Aethlon Medical’s (Nasdaq: AEMD) Exosome Sciences Announces the Publication of Preliminary Findings of a Blood Test to Detect Chronic Traum...
Wednesday, February 17, 2016

QBioMed Inc. (OTCQB: QBIO) Corporate Update; Licensed Mannin Research Glaucoma Technology Advancing on Schedule

›
QBioMed Inc. (OTCQB: QBIO) Corporate Update; Licensed Mannin Research Glaucoma Technology Advancing on Schedule       NEW YORK, NY...
Tuesday, February 16, 2016

Q BioMed Inc. (OTCQB:QBIO) To Present at the SeeThruEquity & The Brewer Group 2nd Annual Innovations Investor Conference at the Ritz in South Beach on Feb. 22, 2016

›
Q BioMed Inc. (OTCQB:QBIO) To Present at the SeeThruEquity & The Brewer Group 2 nd Annual Innovations Investor Conference at the Ritz ...
Tuesday, January 12, 2016

Aethlon Medical’s (Nasdaq: AEMD) ExosomeSciences to Participate in Clinical Research Study To Diagnose Chronic Traumatic Encephalopathy (CTE)

›
Aethlon Medical’s (Nasdaq: AEMD) ExosomeSciences to Participate in Clinical Research Study To Diagnose Chronic Traumatic Encephalopathy (CT...
Wednesday, December 23, 2015

›
Aethlon Medical (Nasdaq:AEMD) CEO Jim Joyce Discusses the Forthcoming Concussion Movie and CTE Research Research Being Conducted by Aet...